SOST and Huntington disease: In terms of circulating biomarkers, serum levels of FGF 23 were notably lower (p < 0.001) in the pre-HD group, while serum Fetuin-A and sclerostin concentrations were significantly higher (p < 0.001) in comparison to the HD group.